The Role of Concomitant Nrf2 Targeting and Stem Cell Therapy in Cerebrovascular Disease
Despite the reality that a death from cerebrovascular accident occurs every 3.5 min in the United States, there are few therapeutic options which are typically limited to a narrow window of opportunity in time for damage mitigation and recovery. Novel therapies have targeted pathological processes s...
Furkejuvvon:
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
MDPI AG
2022-07-01
|
| Ráidu: | Antioxidants |
| Fáttát: | |
| Liŋkkat: | https://www.mdpi.com/2076-3921/11/8/1447 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|